• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服避孕药使用者的死亡率。皇家全科医师学院口服避孕研究。

Mortality among oral-contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

作者信息

Beral V

出版信息

Lancet. 1977 Oct 8;2(8041):727-31.

PMID:71539
Abstract

In a large prospective study carried out in the United Kingdom, the death-rate from diseases of the circulatory system in women who had used oral contraceptives was five times that of controls who had never used them; and the death-rate in those who had taken the pill continuously for 5 years or more was ten times that of the controls. The excess deaths in oral-contraceptive users were due to a wide range of vascular conditions. The total mortality-rate in women who had ever used the pill was increased by 40%, and this was due to an increase in deaths from circulatory diseases of 1 per 5000 ever-users per year. The excess was substantially greater than the death-rate from complications of pregnancy in the controls, and was double the death-rate from accidents. The excess mortality-rate increased with age, cigarette smoking, and duration of oral contraceptive use.

摘要

在英国进行的一项大型前瞻性研究中,使用口服避孕药的女性患循环系统疾病的死亡率是从未使用过口服避孕药的对照组女性的五倍;连续服用避孕药5年或更长时间的女性的死亡率是对照组的十倍。口服避孕药使用者的额外死亡是由多种血管疾病导致的。曾经使用过避孕药的女性的总死亡率增加了40%,这是由于每5000名曾经使用过避孕药的女性中,每年因循环系统疾病死亡的人数增加了1人。这一额外死亡率大大高于对照组中因妊娠并发症导致的死亡率,是意外事故死亡率的两倍。额外死亡率随着年龄、吸烟情况以及口服避孕药使用时间的增加而上升。

相似文献

1
Mortality among oral-contraceptive users. Royal College of General Practitioners' Oral Contraception Study.口服避孕药使用者的死亡率。皇家全科医师学院口服避孕研究。
Lancet. 1977 Oct 8;2(8041):727-31.
2
[Oral contraception and circulatory risks].[口服避孕药与循环系统风险]
Contracept Fertil Sex (Paris). 1984 Oct;12(10):1111-6.
3
Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.口服避孕药使用者死亡率的进一步分析。皇家全科医师学院口服避孕研究。
Lancet. 1981 Mar 7;1(8219):541-6.
4
Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.口服避孕药使用相关的死亡率:对皇家全科医师学院口服避孕药研究中46000名女性队列进行的25年随访
BMJ. 1999 Jan 9;318(7176):96-100. doi: 10.1136/bmj.318.7176.96.
5
The Royal College of General Practitioners' Oral Contraception Study: some recent observations.皇家全科医师学院口服避孕药研究:近期一些观察结果。
Clin Obstet Gynaecol. 1984 Dec;11(3):759-86.
6
Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.口服避孕药使用者中动脉疾病的发病率。皇家全科医师学院口服避孕研究。
J R Coll Gen Pract. 1983 Feb;33(247):75-82.
7
Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study.避孕药使用者的死亡率:皇家全科医师学院口服避孕药研究的队列证据。
BMJ. 2010 Mar 11;340:c927. doi: 10.1136/bmj.c927.
8
Death rates and the pill.死亡率与避孕药
CCL News. 1977 Nov-Dec;4(3):3.
9
The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.口服避孕药使用者患重病的风险:来自皇家全科医师学院口服避孕药研究的证据。
Br J Gen Pract. 1998 Oct;48(435):1657-62.
10
Recommendations arising out of the findings by the RCGP oral contraception sutdy on the mortality risks of oral contraceptive users. From the Royal College of General Practitioners and the Royal College of Obstetricians nad Gynaecologists.皇家全科医师学院口服避孕药研究关于口服避孕药使用者死亡风险的研究结果所产生的建议。来自皇家全科医师学院以及皇家妇产科学院。 (注:原文中“nad”应为“and”的错误拼写)
J R Coll Gen Pract. 1977 Nov;27(184):700.

引用本文的文献

1
Medical screening of sports divers.运动潜水员的医学筛查。
Can Fam Physician. 1982 Oct;28:1850-4.
2
Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study.避孕药使用者的死亡率:皇家全科医师学院口服避孕药研究的队列证据。
BMJ. 2010 Mar 11;340:c927. doi: 10.1136/bmj.c927.
3
The contraceptive revolution: some excellent progress but work still to be done.避孕革命:取得了一些卓越进展,但仍有工作要做。
Br J Gen Pract. 2009 Jan;59(558):4-6. doi: 10.3399/bjgp09X394789.
4
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.口服避孕药使用者的闭塞性血管疾病。流行病学、病理学及发病机制。
Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003.
5
Is there an increased risk of stroke associated with oral contraceptives?口服避孕药会增加中风风险吗?
Drug Saf. 1999 Jun;20(6):467-73. doi: 10.2165/00002018-199920060-00001.
6
Danazol in the treatment of menorrhagia.达那唑治疗月经过多。
Drugs. 1980 May;19(5):342-8. doi: 10.2165/00003495-198019050-00003.
7
Massive arterial thrombosis and oral contraception.大面积动脉血栓形成与口服避孕药
Br Med J. 1980 Feb 2;280(6210):332. doi: 10.1136/bmj.280.6210.332-a.
8
Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.英国药理学会临床药理学分会会议记录,1980年12月16日至18日,伦敦大学。摘要
Br J Clin Pharmacol. 1981 Apr;11(4):409P-439P. doi: 10.1111/j.1365-2125.1981.tb01148.x.
9
Problem patients and the 'pill'.问题患者与“药物”。
Drugs. 1981 Feb;21(2):152-6. doi: 10.2165/00003495-198121020-00005.
10
Lipid and carbohydrate metabolism studies in oophorectomized women: effects produced by the addition of norethisterone acetate to two estrogen preparations.卵巢切除术后女性的脂质和碳水化合物代谢研究:在两种雌激素制剂中添加醋酸炔诺酮所产生的影响。
Arch Gynecol. 1982;231(4):279-87. doi: 10.1007/BF02111726.